STAT

Her son died. Two decades later, she met the medical student who got his heart

The young man handed her a stethoscope, opened his shirt, and pointed to where she should place it. Hesitantly, she reached forward, pressed it to his skin, and broke into tears.

The heart Elisabeth Tilly heard inside the chest of a 25-year-old stranger was the same that once beat inside her son. Christopher, age 8, was killed more than two decades ago, by a truck barreling through a crosswalk in front of his elementary school. But the memory of her grievously injured son lying in a Salt Lake City hospital is still raw.

A few doors down from Christopher, 4-year-old Jon Hochstein was fighting for his life. His heart had enlarged, damaged beyond repair, perhaps by a passing virus, or just bad luck. His family wasn’t sure he would make it through the night.

Tilly didn’t want to donate Christopher’s organs. He’d need them in heaven, she thought. But then she saw Hochstein’s tiny legs poking out from under the sheets.

She decided that this little boy needed Christopher’s heart more than he did.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks